Cargando…
The Protective Effect of Sheng Mai Yin on Diabetic Cardiomyopathy via NLRP3/Caspase-1 Pathway
Sheng Mai Yin (SMY) has therapeutic effects on myocardial infarction (MI), heart failure (HF), diabetic cardiomyopathy (DCM), and myocarditis. To study whether SMY can relieve pyroptosis and play a protective role in diabetic cardiomyopathy, a molecular docking technique was used to predict the poss...
Autores principales: | Li, Jing-Ya, Zhao, Chun-Chun, Peng, Jian-Fei, Zhang, Meng, Wang, Liang, Yin, Gang, Zhou, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9731757/ https://www.ncbi.nlm.nih.gov/pubmed/36506810 http://dx.doi.org/10.1155/2022/1234434 |
Ejemplares similares
-
Sheng-Mai-Yin inhibits doxorubicin-induced ferroptosis and cardiotoxicity through regulation of Hmox1
por: Meng, Peina, et al.
Publicado: (2023) -
Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats
por: Ma, Shaojun, et al.
Publicado: (2016) -
Protective Effects of Sheng-Mai-San on Right Ventricular Dysfunction during Chronic Intermittent Hypoxia in Mice
por: Chai, Cheng-Zhi, et al.
Publicado: (2016) -
Sheng Mai San protects H9C2 cells against hyperglycemia-induced apoptosis
por: Pang, Bing, et al.
Publicado: (2019) -
Mechanism of new optimized Sheng-Mai-San Formula to regulate cardiomyocyte apoptosis through NMDAR pathway
por: Hou, Yazhu, et al.
Publicado: (2023)